Literature DB >> 6359383

Antimicrobial prophylaxis of infections in head and neck cancer surgery.

M Piccart, P Dor, J Klastersky.   

Abstract

429 patients undergoing surgery for head and neck tumors were involved in 4 consecutive, randomized clinical trials of antimicrobial prophylaxis: placebo versus ampicillin plus cloxacillin (2 g of each daily for 6 days), ticarcillin (5 g X 12, 8-hourly) versus carbenicillin (10 g X 12, 8-hourly) short carbenicillin prophylaxis (1 day) versus prolonged carbenicillin prophylaxis (4 days) and clindamycin (900 mg, 4 daily doses) versus clindamycin plus netilmicin (90 mg, 4 daily doses). Aerobic gram-negative strains were the microorganisms most frequently isolated either from colonized or infected wounds. The first controlled study showed a significant decrease in the rate of postoperative bacterial infections in the treated group as compared to the placebo-treated group (p less than 0.05). In all the subsequent treatment groups, postoperative infection rates ranged from 6 to 16%. Short prophylaxis was as effective as prolonged prophylaxis. A regimen directed mainly against anaerobes (clindamycin) did not seem of less value than broad spectrum regimens covering most aerobic gram-negative bacilli.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6359383

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  9 in total

1.  Post-operative wound infection in salvage laryngectomy: does antibiotic prophylaxis have an impact?

Authors:  William Scotton; Richard Cobb; Leo Pang; Iain Nixon; Anil Joshi; Jeanne-Pierre Jeannon; Richard Oakley; Gary French; Carolyn Hemsley; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-01-25       Impact factor: 2.503

Review 2.  [Prophylactic antibiotic use in ENT surgery].

Authors:  C Thorn; A Faber; J D Schultz; K Hörmann; B A Stuck
Journal:  HNO       Date:  2015-02       Impact factor: 1.284

3.  Antimicrobial prophylaxis for major head and neck surgery in cancer patients.

Authors:  M Gerard; F Meunier; P Dor; G Andry; G Chantrain; P Van der Auwera; D Daneau; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

4.  Antibiotic use during major head and neck surgery.

Authors:  J T Johnson; V L Yu
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

5.  Cefonicid versus clindamycin prophylaxis for head and neck surgery in a randomized, double-blind trial, with pharmacokinetic implications.

Authors:  D Swanson; R A Maxwell; J T Johnson; R L Wagner; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

6.  Prognostic significance of wound infections following major head and neck cancer surgery: an open non-comparative prospective study.

Authors:  Nicolas Penel; Charles Fournier; Micheline Roussel-Delvallez; Danièle Lefebvre; Ahmed Kara; Yann Mallet; Jean-Charles Neu; Jean-Louis Lefebvre
Journal:  Support Care Cancer       Date:  2004-09       Impact factor: 3.603

Review 7.  Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; S Chaplin; R H Sayce; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

8.  Antimicrobial prophylaxis for major head and neck surgery in cancer patients: sulbactam-ampicillin versus clindamycin-amikacin.

Authors:  M Phan; P Van der Auwera; G Andry; M Aoun; G Chantrain; R Deraemaecker; P Dor; D Daneau; P Ewalenko; F Meunier
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

Review 9.  Evidence and evidence gaps of laryngeal cancer surgery.

Authors:  Susanne Wiegand
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.